NCT00250341View on ClinicalTrials.gov

Non-invasive Measures of Distal Lung Disease in Asthmatics

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Asthma
Interventions
DRUG

QVAR

480 mcg

DRUG

Advair

250/50 mcg

DRUG

Servent Diskus

50 mcg

Trial Locations (1)

90095

UCLA, Los Angeles

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00250341 - Non-invasive Measures of Distal Lung Disease in Asthmatics | Biotech Hunter | Biotech Hunter